Liminatus Pharma, Inc. Class A Common Stock (LIMN) Q1 2026 Annual Earnings
LIMN·Reported May 15, 2026·Before market open
Diluted EPS came in at $-0.03.
Diluted EPS
$-0.03
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Liminatus Pharma, Inc. Class A Common Stock's Q1 2026 earnings report.
Liminatus Pharma, Inc. Class A Common Stock (LIMN) reported Q1 2026 earnings on May 15, 2026 before market open.
Liminatus Pharma, Inc. Class A Common Stock reported diluted EPS of $-0.03 for Q1 2026.
You can read the 10-K periodic report (0001104659-26-037933) directly on SEC EDGAR. The filing index links above go to sec.gov.